Semax

Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH) fragment 4–7, modified for enhanced stability and biological activity. Specifically, originally developed in Russia for clinical neurological applications, Semax has since become a widely researched nootropic peptide with an extensive body of preclinical literature examining its cognitive and neuroprotective properties. semax peptide​

Mechanistically, studies have investigated its influence on the release and modulation of brain-derived neurotrophic factor (BDNF), which plays a critical role in neuronal survival, synaptic plasticity, and memory formation. In addition, research has explored how Semax interacts with dopaminergic and serotonergic neurotransmitter systems, with findings suggesting it may enhance focus, learning efficiency, and memory consolidation. semax peptide​

Furthermore, its anti-inflammatory and antioxidant properties within neural tissue have been a major focus of inquiry, particularly in studies examining its potential to protect neurons against ischemic damage and oxidative injury. Overall, researchers studying cognitive enhancement, neuroprotection, and the biochemical underpinnings of mood and attention regulation continue to find Semax a compound of significant scientific interest.